Scholarlink

Background <p>Necroptosis represents a kind for designed lysate cell death pathway as well as a regulated necrotic cells dying mode controlled through&#xa0;RIP1 as well as RIP3 kinases.</p> Objective <p>Within the present research, we analyzed genes linked to cell necroptosis to determine three stable molecular categories (C1, C2, C3) for head and neck squamous cell carcinoma (HNSCC) through consensus clustering.</p> Methods <p>The three stable molecular categories were having distinct prognostic, mutational, as well as immune characteristics. TP53 and CDKN2A presented high mutation frequency in the three subtypes. The results showed substantial variations among C1 as well as&#xa0;C3 categories within T, Stage, Grade, age along with additional clinicopathologic features. It has been utilized to find gene sections linked to molecular categories. Ultimately, seven genes (KIR3DX1, GRAP, FGD3, CTSG, CCL22, TPP1, and MCEMP1) were identified as cell necroptosis-related genes that influence prognostic. The risk score of necroptosis-related prognostic gene (NPRS) for each cell has been calculated according to the formula. Then, the mutations, pathways, and immune features of NPRS undergone additional research based on the NPRS grouping, and the differences in immunotherapy/chemotherapy were compared. The results show that NPRS is negatively correlated with prognostic. As a whole, the triggered processes within the NPRS-high category were primarily cell cycle-related processes, while the activated processes within the NPRS-low group were mainly immune-related pathways. The stimulation for cell cycle-related processes as well as the inhibition of immune-related processes within the NPRS-high category could represent possible variables contributing to a negative prognostic.</p> Results <p>We evaluated the immune cell infiltration among individuals within the TCGA-HNSC cohort via the expression level for gene markers within immune cells, which had been greater within the NPRS-low category. The possibility for immune escape was higher in NPRS-high group, which makes it harder to reap advantages via immunotherapy. Furthermore, a significant positive association was found among NPRS, myeloid-derived suppressor cells (MDSC), and fibroblast (CAF) along with Exclusion. Besides, the response degree of NPRS to standard chemotherapy medications has been investigated, and it turned out which NPRS-high was particularly responsive to Docetaxel as well as Cisplatin.</p> Conclusion <p>In our research, we constructed a prognostic scoring structure related to necroptosis that well reflected the likelihood as well as beneficial variables over prognostic individuals alongside head and neck squamous cell carcinoma. That may be utilized to direct customized adjuvant treatment as well as radiation therapy for individuals alongside head and neck cancer. As a result, it can accurately predict survival as well as serves as a valuable healthcare reference.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Seven necroptosis-related genetic signatures to predict the survival rate of individuals suffering from head and neck squamous cell carcinoma through influencing immune regulation

  • 期刊论文

  • 发表日期：

    2025年7月21日

查看全文
  • Biao Zhuang,
  • Haoxi Cai,
  • Jinyang Zheng,
  • Yunxia Lv,
  • Hui Ye,
  • Chengfu Cai,
  • Gengming Cai

摘要

Background

Necroptosis represents a kind for designed lysate cell death pathway as well as a regulated necrotic cells dying mode controlled through RIP1 as well as RIP3 kinases.

Objective

Within the present research, we analyzed genes linked to cell necroptosis to determine three stable molecular categories (C1, C2, C3) for head and neck squamous cell carcinoma (HNSCC) through consensus clustering.

Methods

The three stable molecular categories were having distinct prognostic, mutational, as well as immune characteristics. TP53 and CDKN2A presented high mutation frequency in the three subtypes. The results showed substantial variations among C1 as well as C3 categories within T, Stage, Grade, age along with additional clinicopathologic features. It has been utilized to find gene sections linked to molecular categories. Ultimately, seven genes (KIR3DX1, GRAP, FGD3, CTSG, CCL22, TPP1, and MCEMP1) were identified as cell necroptosis-related genes that influence prognostic. The risk score of necroptosis-related prognostic gene (NPRS) for each cell has been calculated according to the formula. Then, the mutations, pathways, and immune features of NPRS undergone additional research based on the NPRS grouping, and the differences in immunotherapy/chemotherapy were compared. The results show that NPRS is negatively correlated with prognostic. As a whole, the triggered processes within the NPRS-high category were primarily cell cycle-related processes, while the activated processes within the NPRS-low group were mainly immune-related pathways. The stimulation for cell cycle-related processes as well as the inhibition of immune-related processes within the NPRS-high category could represent possible variables contributing to a negative prognostic.

Results

We evaluated the immune cell infiltration among individuals within the TCGA-HNSC cohort via the expression level for gene markers within immune cells, which had been greater within the NPRS-low category. The possibility for immune escape was higher in NPRS-high group, which makes it harder to reap advantages via immunotherapy. Furthermore, a significant positive association was found among NPRS, myeloid-derived suppressor cells (MDSC), and fibroblast (CAF) along with Exclusion. Besides, the response degree of NPRS to standard chemotherapy medications has been investigated, and it turned out which NPRS-high was particularly responsive to Docetaxel as well as Cisplatin.

Conclusion

In our research, we constructed a prognostic scoring structure related to necroptosis that well reflected the likelihood as well as beneficial variables over prognostic individuals alongside head and neck squamous cell carcinoma. That may be utilized to direct customized adjuvant treatment as well as radiation therapy for individuals alongside head and neck cancer. As a result, it can accurately predict survival as well as serves as a valuable healthcare reference.